URIBEL TABS 9 mg/1
Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate · TABLET, COATED · Mission Pharmacal Company
URIBEL TABS is a tablet, coated containing methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate at 9 mg/1, taken oral. Manufactured by Mission Pharmacal Company.
Key Facts
- Brand Name
- URIBEL TABS
- Generic Name
- Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
- NDC Code (Product)
0178-0745- Manufacturer
- Mission Pharmacal Company
- Strength
- 9 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Drug Class
- Nitrogen Binding Agent [EPC]
- Marketing Start
- 11/07/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is URIBEL TABS used for?
URIBEL TABS contains Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is URIBEL TABS a controlled substance?
URIBEL TABS is not classified as a controlled substance by the DEA.
What is the generic name for URIBEL TABS?
The generic name for URIBEL TABS is Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate. There are no other listed brand versions of Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate.
What is the NDC code for URIBEL TABS 9 mg/1?
The NDC (National Drug Code) for URIBEL TABS 9 mg/1 is 0178-0745, listed by Mission Pharmacal Company.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)